Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Clinical study of analgesia in brachytherapy for cervical cancer

Clinical study of analgesia in brachytherapy for cervical cancer INTRODUCTIONCervical cancer is a common malignant gynecological tumor, and it is the fourth most common gynecological tumor.1 It is expected that 111,820 new cases of cervical cancer and 61,579 related deaths occurred in China by 2022.2 Brachytherapy is an important component of radical radiotherapy used for cervical cancer.3 During brachytherapy for cervical cancer, the patient must undergo a series of processes in sequence: applicator placement and fixation, simulated positioning scanning, waiting for treatment (gynecological radiation oncologists outline the target area and organs at risk, and physicians design the brachytherapy plan), treatment, and removal of the applicator. The pain that may occur during applicator placement, removal, and transport is usually underestimated.4 Based on the fact that the patient's pain is the most obvious when the applicator is placed, removed and simulated positioning, the patient's anxiety and depression are the most serious before brachytherapy,5 and there is a correlation between the anxiety before brachytherapy and the pain during the treatment.6 This study aimed to investigate the effect of analgesia on the physical and mental health and the clinical efficacy of three‐dimensional (3D) brachytherapy in patients with cervical cancer.MATERIALS AND METHODSPatient selectionIn this prospective clinical study, 100 patients with cervical squamous cell http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Precision Radiation Oncology Wiley

Clinical study of analgesia in brachytherapy for cervical cancer

5 pages

Loading next page...
 
/lp/wiley/clinical-study-of-analgesia-in-brachytherapy-for-cervical-cancer-P2AOfhLLQP
Publisher
Wiley
Copyright
© 2023 Shandong Cancer Hospital & Institute.
ISSN
2398-7324
eISSN
2398-7324
DOI
10.1002/pro6.1194
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONCervical cancer is a common malignant gynecological tumor, and it is the fourth most common gynecological tumor.1 It is expected that 111,820 new cases of cervical cancer and 61,579 related deaths occurred in China by 2022.2 Brachytherapy is an important component of radical radiotherapy used for cervical cancer.3 During brachytherapy for cervical cancer, the patient must undergo a series of processes in sequence: applicator placement and fixation, simulated positioning scanning, waiting for treatment (gynecological radiation oncologists outline the target area and organs at risk, and physicians design the brachytherapy plan), treatment, and removal of the applicator. The pain that may occur during applicator placement, removal, and transport is usually underestimated.4 Based on the fact that the patient's pain is the most obvious when the applicator is placed, removed and simulated positioning, the patient's anxiety and depression are the most serious before brachytherapy,5 and there is a correlation between the anxiety before brachytherapy and the pain during the treatment.6 This study aimed to investigate the effect of analgesia on the physical and mental health and the clinical efficacy of three‐dimensional (3D) brachytherapy in patients with cervical cancer.MATERIALS AND METHODSPatient selectionIn this prospective clinical study, 100 patients with cervical squamous cell

Journal

Precision Radiation OncologyWiley

Published: Jun 1, 2023

Keywords: analgesia; cervical cancer; physical and mental health; satisfaction rate; three‐dimensional brachytherapy

References